Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 MAGI3-AKT3 fusion in breast cancer amended.

Literature DB >> 25877206

MAGI3-AKT3 fusion in breast cancer amended.

Juan-Miguel Mosquera¹, Sonal Varma², Chantal Pauli³, Theresa Y MacDonald², Jossie J Yashinskie², Zsuzsanna Varga⁴, Andrea Sboner⁵, Holger Moch⁴, Mark A Rubin¹, Sandra J Shin².

Abstract

Entities: Disease Gene

Mesh：

Year: 2015 PMID： 25877206 DOI： 10.1038/nature14265

Source DB: PubMed Journal: Nature ISSN： 0028-0836 Impact factor: 49.962

× No keyword cloud information.

13 in total

1. Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing.

Authors: Dorothee Pflueger; Stéphane Terry; Andrea Sboner; Lukas Habegger; Raquel Esgueva; Pei-Chun Lin; Maria A Svensson; Naoki Kitabayashi; Benjamin J Moss; Theresa Y MacDonald; Xuhong Cao; Terrence Barrette; Ashutosh K Tewari; Mark S Chee; Arul M Chinnaiyan; David S Rickman; Francesca Demichelis; Mark B Gerstein; Mark A Rubin
Journal: Genome Res Date: 2010-10-29 Impact factor: 9.043

2. Novel MIR143-NOTCH fusions in benign and malignant glomus tumors.

Authors: Juan-Miguel Mosquera; Andrea Sboner; Lei Zhang; Chun-Liang Chen; Yun-Shao Sung; Hsiao-Wei Chen; Narasimhan P Agaram; Daniel Briskin; Basma M Basha; Samuel Singer; Mark A Rubin; Thomas Tuschl; Cristina R Antonescu
Journal: Genes Chromosomes Cancer Date: 2013-09-02 Impact factor: 5.006

3. STAR: ultrafast universal RNA-seq aligner.

Authors: Alexander Dobin; Carrie A Davis; Felix Schlesinger; Jorg Drenkow; Chris Zaleski; Sonali Jha; Philippe Batut; Mark Chaisson; Thomas R Gingeras
Journal: Bioinformatics Date: 2012-10-25 Impact factor: 6.937

Review 4. Triple negative breast cancer: unmet medical needs.

Authors: Sumanta Kumar Pal; Barrett H Childs; Mark Pegram
Journal: Breast Cancer Res Treat Date: 2010-12-15 Impact factor: 4.872

5. TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer.

Authors: Sven Perner; Francesca Demichelis; Rameen Beroukhim; Folke H Schmidt; Juan-Miguel Mosquera; Sunita Setlur; Joelle Tchinda; Scott A Tomlins; Matthias D Hofer; Kenneth G Pienta; Rainer Kuefer; Robert Vessella; Xiao-Wei Sun; Matthew Meyerson; Charles Lee; William R Sellers; Arul M Chinnaiyan; Mark A Rubin
Journal: Cancer Res Date: 2006-09-01 Impact factor: 12.701

6. Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma.

Authors: Juan Miguel Mosquera; Andrea Sboner; Lei Zhang; Naoki Kitabayashi; Chun-Liang Chen; Yun Shao Sung; Leonard H Wexler; Michael P LaQuaglia; Morris Edelman; Chandrika Sreekantaiah; Mark A Rubin; Cristina R Antonescu
Journal: Genes Chromosomes Cancer Date: 2013-03-05 Impact factor: 5.006

7. Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities.

Authors: David W Craig; Joyce A O'Shaughnessy; Jeffrey A Kiefer; Jessica Aldrich; Shripad Sinari; Tracy M Moses; Shukmei Wong; Jennifer Dinh; Alexis Christoforides; Joanne L Blum; Cristi L Aitelli; Cynthia R Osborne; Tyler Izatt; Ahmet Kurdoglu; Angela Baker; Julie Koeman; Catalin Barbacioru; Onur Sakarya; Francisco M De La Vega; Asim Siddiqui; Linh Hoang; Paul R Billings; Bodour Salhia; Anthony W Tolcher; Jeffrey M Trent; Spyro Mousses; Daniel Von Hoff; John D Carpten
Journal: Mol Cancer Ther Date: 2012-11-19 Impact factor: 6.261

8. The genomic complexity of primary human prostate cancer.

Authors: Michael F Berger; Michael S Lawrence; Francesca Demichelis; Yotam Drier; Kristian Cibulskis; Andrey Y Sivachenko; Andrea Sboner; Raquel Esgueva; Dorothee Pflueger; Carrie Sougnez; Robert Onofrio; Scott L Carter; Kyung Park; Lukas Habegger; Lauren Ambrogio; Timothy Fennell; Melissa Parkin; Gordon Saksena; Douglas Voet; Alex H Ramos; Trevor J Pugh; Jane Wilkinson; Sheila Fisher; Wendy Winckler; Scott Mahan; Kristin Ardlie; Jennifer Baldwin; Jonathan W Simons; Naoki Kitabayashi; Theresa Y MacDonald; Philip W Kantoff; Lynda Chin; Stacey B Gabriel; Mark B Gerstein; Todd R Golub; Matthew Meyerson; Ashutosh Tewari; Eric S Lander; Gad Getz; Mark A Rubin; Levi A Garraway
Journal: Nature Date: 2011-02-10 Impact factor: 49.962

9. Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer.

Authors: Dan R Robinson; Shanker Kalyana-Sundaram; Yi-Mi Wu; Sunita Shankar; Xuhong Cao; Bushra Ateeq; Irfan A Asangani; Matthew Iyer; Christopher A Maher; Catherine S Grasso; Robert J Lonigro; Michael Quist; Javed Siddiqui; Rohit Mehra; Xiaojun Jing; Thomas J Giordano; Michael S Sabel; Celina G Kleer; Nallasivam Palanisamy; Rachael Natrajan; Maryou B Lambros; Jorge S Reis-Filho; Chandan Kumar-Sinha; Arul M Chinnaiyan
Journal: Nat Med Date: 2011-11-20 Impact factor: 53.440

10. FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNA-sequencing data.

Authors: Andrea Sboner; Lukas Habegger; Dorothee Pflueger; Stephane Terry; David Z Chen; Joel S Rozowsky; Ashutosh K Tewari; Naoki Kitabayashi; Benjamin J Moss; Mark S Chee; Francesca Demichelis; Mark A Rubin; Mark B Gerstein
Journal: Genome Biol Date: 2010-10-21 Impact factor: 13.583

11 in total

1. Landscape analysis of adjacent gene rearrangements reveals BCL2L14-ETV6 gene fusions in more aggressive triple-negative breast cancer.

Authors: Sanghoon Lee; Yiheng Hu; Suet Kee Loo; Ying Tan; Rohit Bhargava; Michael T Lewis; Xiao-Song Wang
Journal: Proc Natl Acad Sci U S A Date: 2020-04-22 Impact factor: 11.205

2. Pugh et al. reply.

Authors: Trevor J Pugh; Shantanu Banerji; Matthew Meyerson
Journal: Nature Date: 2015-04-16 Impact factor: 49.962

3. Cancer: hunting rare somatic mutations.

Authors: Vivien Marx
Journal: Nat Methods Date: 2016-03-30 Impact factor: 28.547

4. Patient-Driven Discovery, Therapeutic Targeting, and Post-Clinical Validation of a Novel AKT1 Fusion-Driven Cancer.

Authors: Emily K Slotkin; Daniel Diolaiti; Neerav N Shukla; Filemon S Dela Cruz; Jennifer J Clark; Gunes Gundem; Venkata D Yellapantula; Max F Levine; Daoqi You; Peilin Ma; Sagarika Pachhal; Glorymar Ibanez Sanchez; Ryma Benayed; Achim A Jungbluth; Lillian M Smyth; Audrey Mauguen; Irena Gushterova; Hongxu Ding; Lee Spraggon; Robert Darnell; Andrea Califano; Marc Ladanyi; Elli Papaemmanuil; Andrew L Kung; David M Hyman; Stephen S Roberts
Journal: Cancer Discov Date: 2019-03-15 Impact factor: 39.397

5. MicroRNA-433 targets AKT3 and inhibits cell proliferation and viability in breast cancer.

Authors: Xiaolei Hu; Jie Wang; Wan He; Pan Zhao; Changsheng Ye
Journal: Oncol Lett Date: 2018-01-16 Impact factor: 2.967

Review 6. Recurrent and pathological gene fusions in breast cancer: current advances in genomic discovery and clinical implications.

Authors: Jamunarani Veeraraghavan; Jiacheng Ma; Yiheng Hu; Xiao-Song Wang
Journal: Breast Cancer Res Treat Date: 2016-07-02 Impact factor: 4.872

Review 10. Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants.

Authors: Fresia Pareja; Felipe C Geyer; Caterina Marchiò; Kathleen A Burke; Britta Weigelt; Jorge S Reis-Filho
Journal: NPJ Breast Cancer Date: 2016-11-16